Abstract
The connexin 26 (CX26) gene suppresses the growth of HeLa cells in vitro and in vivo. We explored the possibility that the Cx26 gene not only suppresses growth but can also mediate the bystander effect that is observed in some gene therapy. In gene therapy mediated by the herpes simplex virus thymidine kinase, the toxicity of ganciclovir affects not only the cells transduced with the gene but also affects neighboring tumor cells; it has been suggested that gap junctional intercellular communication (GJIC) may play a role in such a bystander effect. HeLa cells expressing the Cx26 gene (Cx26+) or not expressing the Cx26 gene were transfected with the herpes simplex virus thymidine kinase (tk+) gene, producing Cx26--tk-, Cx26--tk+, Cx26+-tk-, and Cx26+-tk+ cells. By making different kinds of cocultures of these cells, we observed a clear bystander killing effect, assessed by the neutral red toxicity test, in the coculture of Cx26+-tk-/Cx26+-tk+ cells. The bystander effect was markedly prevented by a long-term inhibitor of GJIC, 18-α-glycyrrhetinic acid, demonstrating that a major part of the bystander effect seen occurred through Cx-mediated GJIC. These data suggest the possibility of using of Cxs as both tumor suppressor genes and as diffusers of ganciclovir toxicity in therapeutic approaches.
Footnotes
-
↵1 Part of this work was financially supported by European Commission Environment Program Grant CT940421 (to H. Y.) and by Grants 96-27 from the Association for International Cancer Research (St. Andrews, Scotland) and from the Association pour la Recherche sur le Cancer (to M. M.)
-
↵2 To whom requests for reprints should be addressed. Phone: 33(0)472-73-85-90; Fax: 33(0)472-73-84-42; E-mail: mesnil@iarc.fr.
- Received January 13, 1997.
- Accepted May 14, 1997.
- ©1997 American Association for Cancer Research.